130 related articles for article (PubMed ID: 18571404)
1. Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.
Middleton DS; Andrews M; Glossop P; Gymer G; Hepworth D; Jessiman A; Johnson PS; Mackenny M; Pitcher MJ; Rooker T; Stobie A; Tang K; Morgan P
Bioorg Med Chem Lett; 2008 Jul; 18(14):4018-21. PubMed ID: 18571404
[TBL] [Abstract][Full Text] [Related]
2. Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.
Middleton DS; Andrews M; Glossop P; Gymer G; Hepworth D; Jessiman A; Johnson PS; MacKenny M; Stobie A; Tang K; Morgan P; Jones B
Bioorg Med Chem Lett; 2008 Oct; 18(19):5303-6. PubMed ID: 18782666
[TBL] [Abstract][Full Text] [Related]
3. Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
Letavic MA; Stocking EM; Barbier AJ; Bonaventure P; Boggs JD; Lord B; Miller KL; Wilson SJ; Carruthers NI
Bioorg Med Chem Lett; 2007 Sep; 17(17):4799-803. PubMed ID: 17616397
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.
Keith JM; Gomez LA; Wolin RL; Barbier AJ; Wilson SJ; Boggs JD; Mazur C; Fraser IC; Lord B; Aluisio L; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 May; 17(9):2603-7. PubMed ID: 17317177
[TBL] [Abstract][Full Text] [Related]
5. 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.
Vu AT; Cohn ST; Terefenko EA; Moore WJ; Zhang P; Mahaney PE; Trybulski EJ; Goljer I; Dooley R; Bray JA; Johnston GH; Leiter J; Deecher DC
Bioorg Med Chem Lett; 2009 May; 19(9):2464-7. PubMed ID: 19329313
[TBL] [Abstract][Full Text] [Related]
6. Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.
Letavic MA; Keith JM; Ly KS; Barbier AJ; Boggs JD; Wilson SJ; Lord B; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 May; 17(9):2566-9. PubMed ID: 17307358
[TBL] [Abstract][Full Text] [Related]
7. N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.
Fish PV; Fray MJ; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2007 Apr; 17(7):2022-5. PubMed ID: 17267217
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.
Fray MJ; Bish G; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4349-53. PubMed ID: 16750363
[TBL] [Abstract][Full Text] [Related]
9. N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
Jonathan Fray M; Bish G; Brown AD; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4345-8. PubMed ID: 16750359
[TBL] [Abstract][Full Text] [Related]
10. Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity.
Serafinowska HT; Blaney FE; Lovell PJ; Merlo GG; Scott CM; Smith PW; Starr KR; Watson JM
Bioorg Med Chem Lett; 2008 Oct; 18(20):5581-5. PubMed ID: 18829312
[TBL] [Abstract][Full Text] [Related]
11. Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
Denhart DJ; Deskus JA; Ditta JL; Gao Q; Dalton King H; Kozlowski ES; Meng Z; LaPaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
Bioorg Med Chem Lett; 2009 Aug; 19(15):4031-3. PubMed ID: 19560923
[TBL] [Abstract][Full Text] [Related]
12. Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.
Middleton DS; Andrews M; Glossop P; Gymer G; Jessiman A; Johnson PS; Mackenny M; Pitcher MJ; Rooker T; Stobie A; Tang K; Morgan P
Bioorg Med Chem Lett; 2006 Mar; 16(5):1434-9. PubMed ID: 16314097
[TBL] [Abstract][Full Text] [Related]
13. N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.
Wakenhut F; Fish PV; Fray MJ; Gurrell I; Mills JE; Stobie A; Whitlock GA
Bioorg Med Chem Lett; 2008 Aug; 18(15):4308-11. PubMed ID: 18625557
[TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
Wen H; Qin W; Yang G; Guo Y
Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
[TBL] [Abstract][Full Text] [Related]
15. Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
Ditta JL; Denhart DJ; Deskus JA; Epperson JR; Meng Z; Gao Q; Mattson GK; Lapaglia MA; Taber MT; Molski TF; Lodge NJ; Mattson RJ; Macor JE
Bioorg Med Chem Lett; 2013 May; 23(10):2948-50. PubMed ID: 23578689
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.
Fish PV; Deur C; Gan X; Greene K; Hoople D; Mackenny M; Para KS; Reeves K; Ryckmans T; Stiff C; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2008 Apr; 18(8):2562-6. PubMed ID: 18387300
[TBL] [Abstract][Full Text] [Related]
17. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
18. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
[TBL] [Abstract][Full Text] [Related]
19. Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.
Dalton King H; Denhart DJ; Deskus JA; Ditta JL; Epperson JR; Higgins MA; Kung JE; Marcin LR; Sloan CP; Mattson GK; Molski TF; Krause RG; Bertekap RL; Lodge NJ; Mattson RJ; Macor JE
Bioorg Med Chem Lett; 2007 Oct; 17(20):5647-51. PubMed ID: 17766113
[TBL] [Abstract][Full Text] [Related]
20. Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors.
Boot J; Cases M; Clark BP; Findlay J; Gallagher PT; Hayhurst L; Man T; Montalbetti C; Rathmell RE; Rudyk H; Walter MW; Whatton M; Wood V
Bioorg Med Chem Lett; 2005 Feb; 15(3):699-703. PubMed ID: 15664840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
